Pediatrix Valuation Multiples

Discover revenue and EBITDA valuation multiples for Pediatrix and similar public comparables like Draegerwerk, Dr. Soliman Abdul Kader, Huaxia Eye Hospital Group, Select Medical and more.

Pediatrix Overview

About Pediatrix

Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.


Founded

2007

HQ

United States

Employees

6.6K

Financials (LTM)

Revenue: $1.9B
EBITDA: $284M

EV

$2.3B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Pediatrix Financials

Pediatrix reported last 12-month revenue of $1.9B and EBITDA of $284M.

In the same LTM period, Pediatrix generated $261M in gross profit, $284M in EBITDA, and $165M in net income.

Revenue (LTM)


Pediatrix P&L

In the most recent fiscal year, Pediatrix reported revenue of $1.9B and EBITDA of $274M.

Pediatrix is profitable as of last fiscal year, with gross margin of 26%, EBITDA margin of 14%, and net margin of 9%.

See analyst estimates for Pediatrix
LTMLast FY202320242025202620272028
Revenue$1.9B$1.9B$2B$2B$1.9B
Gross Profit$261M$494M$422M$454M$494M
Gross Margin13%26%21%23%26%
EBITDA$284M$274M$30M($28M)$274M
EBITDA Margin15%14%1%(1%)14%
EBIT Margin12%12%8%9%12%
Net Profit$165M$165M($60M)($99M)$165M
Net Margin8%9%(3%)(5%)9%
Net Debt-$219M---

Financial data powered by Morningstar, Inc.

Pediatrix Stock Performance

Pediatrix has current market cap of $2.1B, and enterprise value of $2.3B.

Market Cap Evolution


Pediatrix's stock price is $26.14.

Pediatrix share price decreased by 2.4% in the last 30 days, and increased by 51.9% in the last year.

Pediatrix has an EPS (earnings per share) of $2.04.

See more trading valuation data for Pediatrix
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$2.3B$2.1B0.2%-2.4%21.4%51.9%$2.04

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Pediatrix Valuation Multiples

Pediatrix trades at 1.2x EV/Revenue multiple, and 8.2x EV/EBITDA.

See NTM and 2027E valuation multiples for Pediatrix

EV / Revenue (LTM)


Pediatrix Financial Valuation Multiples

As of August 12, 2026, Pediatrix has market cap of $2.1B and EV of $2.3B.

Pediatrix has a P/E ratio of 12.9x.

LTMLast FY202320242025202620272028
EV/Revenue1.2x1.2x1.2x1.2x1.2x
EV/EBITDA8.2x8.5x78.3x(82.5x)8.5x
EV/EBIT9.7x10.1x14.8x12.7x10.1x
EV/Gross Profit9.0x4.7x5.6x5.1x4.7x
P/E12.9x12.8x(35.2x)(21.4x)12.8x
EV/FCF11.7x9.3x22.5x12.7x9.3x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Pediatrix Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Pediatrix Margins & Growth Rates

Pediatrix grew revenue by 2% and EBITDA by 6% in the last fiscal year.

In the most recent fiscal year, Pediatrix reported gross margin of 26%, EBITDA margin of 14%, and net margin of 9%.

See estimated margins and future growth rates for Pediatrix

Pediatrix Margins

Last FY202420252026202720282029
Gross Margin26%23%26%14%
EBITDA Margin14%(1%)14%15%
EBIT Margin12%9%12%13%
Net Margin9%(5%)9%8%
FCF Margin13%9%13%10%

Pediatrix Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth2%1%(5%)2%
Gross Profit Growth(46%)8%9%(46%)
EBITDA Growth6%(195%)(1067%)6%
EBIT Growth7%16%26%7%
Net Profit Growth(0%)64%(267%)(0%)
FCF Growth(23%)77%37%(23%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Pediatrix Operational KPIs

Pediatrix's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.0M for the same period.

Pediatrix's Rule of 40 is 17% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Pediatrix's Rule of X is 21% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Pediatrix
LTMLast FY202320242025202620272028
Rule of 4017%17%---
Bessemer Rule of X21%21%---
Revenue per Employee-$0.3M---
Opex per Employee-$0.0M---
G&A Expenses to Revenue12%13%11%12%13%
Opex to Revenue-14%13%13%14%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Pediatrix Competitors

Pediatrix competitors include Draegerwerk, Dr. Soliman Abdul Kader, Huaxia Eye Hospital Group, Select Medical, Surgery Partners, Akdital, Dr Agarwals, Topchoice Medical, Siloam Hospitals and Guardian Pharmacy Service.

Most Pediatrix public comparables operate across Hospitals & Clinics.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Draegerwerk0.6x0.6x8.2x5.1x
Dr. Soliman Abdul Kader2.8x2.7x17.0x17.2x
Huaxia Eye Hospital Group2.7x2.6x11.6x11.7x
Select Medical0.9x0.9x10.2x10.2x
Surgery Partners1.8x1.7x10.3x11.0x
Akdital4.3x3.6x14.6x12.0x
Dr Agarwals8.6x8.0x29.2x29.1x
Topchoice Medical5.8x5.5x18.2x16.3x

This data is available for Pro users. Sign up to see all Pediatrix competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Pediatrix

When was Pediatrix founded?Pediatrix was founded in 2007.
Where is Pediatrix headquartered?Pediatrix is headquartered in United States.
How many employees does Pediatrix have?As of today, Pediatrix has over 6K employees.
Who is the CEO of Pediatrix?Pediatrix's CEO is Mark S. Ordan.
Is Pediatrix publicly listed?Yes, Pediatrix is a public company listed on NYSE.
What is the stock symbol of Pediatrix?Pediatrix trades under MD ticker.
When did Pediatrix go public?Pediatrix went public in 1959.
Who are competitors of Pediatrix?Pediatrix main competitors include Draegerwerk, Dr. Soliman Abdul Kader, Huaxia Eye Hospital Group, Select Medical, Surgery Partners, Akdital, Dr Agarwals, Topchoice Medical, Siloam Hospitals, Guardian Pharmacy Service.
What is the current market cap of Pediatrix?Pediatrix's current market cap is $2.1B.
What is the current revenue of Pediatrix?Pediatrix's last 12 months revenue is $1.9B.
What is the current revenue growth of Pediatrix?Pediatrix revenue growth (NTM/LTM) is 2%.
What is the current EV/Revenue multiple of Pediatrix?Current revenue multiple of Pediatrix is 1.2x.
What is the current EBITDA of Pediatrix?Pediatrix's last 12 months EBITDA is $284M.
What is Pediatrix's EBITDA margin?Pediatrix's last 12 months EBITDA margin is 15%.
What is the current EV/EBITDA multiple of Pediatrix?Current EBITDA multiple of Pediatrix is 8.2x.
What is the current FCF of Pediatrix?Pediatrix's last 12 months FCF is $201M.
What is Pediatrix's FCF margin?Pediatrix's last 12 months FCF margin is 10%.
What is the current EV/FCF multiple of Pediatrix?Current FCF multiple of Pediatrix is 11.7x.
How many companies Pediatrix has acquired to date?Pediatrix hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Pediatrix has invested to date?Pediatrix hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Pediatrix

Lists including Pediatrix

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial